ArticleJournal of the American Academy of Dermatology2020

The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study.

John W Frew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.